Vor Biopharma (VOR)
(Delayed Data from NSDQ)
$0.95 USD
-0.03 (-3.04%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $0.95 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.41 |
EPS Last Quarter | -0.45 |
Last EPS Surprise | -21.62% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.49 |
Next Year | -1.24 |
EPS (TTM) | -1.78 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 10.00M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 10.00M |
Low Estimate | NA | NA | NA | 10.00M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.41 | -0.36 | -1.49 | -1.24 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.36 | -0.35 | -1.52 | -1.41 |
High Estimate | -0.36 | -0.20 | -1.12 | -0.78 |
Low Estimate | -0.47 | -0.47 | -1.68 | -1.55 |
Year ago EPS | -0.45 | -0.49 | -1.75 | -1.49 |
Year over Year Growth Est. | 8.89% | 26.53% | 14.86% | 16.61% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.41 | -0.36 | -1.49 | -1.24 |
7 Days Ago | -0.41 | -0.36 | -1.49 | -1.24 |
30 Days Ago | -0.41 | -0.36 | -1.49 | -1.24 |
60 Days Ago | -0.41 | -0.36 | -1.49 | -1.24 |
90 Days Ago | -0.34 | -0.33 | -1.34 | -1.31 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.41 | -0.36 | -1.49 | -1.24 |
Zacks Consensus Estimate | -0.41 | -0.36 | -1.49 | -1.24 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.45 | -0.39 | -0.49 | -0.45 | NA |
Estimate | -0.37 | -0.49 | -0.46 | -0.42 | NA |
Difference | -0.08 | 0.10 | -0.03 | -0.03 | -0.01 |
Surprise | -21.62% | 20.41% | -6.52% | -7.14% | -3.72% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more